X4 Pharmaceuticals, Inc. (XFOR)

NASDAQ: XFOR · IEX Real-Time Price · USD

1.010

+0.034 (3.49%)

At close: May 31, 2024, 4:00 PM

1.040

+0.030 (2.97%)

After-hours: May 31, 2024, 7:39 PM EDT

X4 Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Revenue	0	0	0	3	0	Upgrade
Gross Profit	0	0	0	3	0	Upgrade
Selling, General & Admin	35.51	27.02	24.7	20.94	17.64	Upgrade
Research & Development	72.02	61.06	50.65	41.93	30.16	Upgrade
Other Operating Expenses	0	-0.51	9.76	0	3.9	Upgrade
Operating Expenses	107.52	87.57	85.11	62.87	51.7	Upgrade
Operating Income	-107.52	-87.57	-85.11	-59.87	-51.7	Upgrade
Interest Expense / Income	5.78	3.99	3.64	2.69	2.15	Upgrade
Other Expense / Income	-12.21	2.28	-0.07	-0.58	-1.04	Upgrade
Pretax Income	-101.09	-93.84	-88.68	-61.98	-52.81	Upgrade
Income Tax	0.08	0.03	0.02	0.15	0	Upgrade
Net Income	-101.17	-93.87	-88.7	-62.13	-52.81	Upgrade
Preferred Dividends	0	2.55	13.94	0	0.59	Upgrade
Net Income Common	-101.17	-96.41	-102.64	-62.13	-53.4	Upgrade
Shares Outstanding (Basic)	178	64	26	20	12	Upgrade
Shares Outstanding (Diluted)	178	64	26	20	12	Upgrade
Shares Change	179.91%	146.71%	28.25%	74.13%	2411.98%	Upgrade
EPS (Basic)	-0.57	-1.52	-3.99	-3.09	-4.63	Upgrade
EPS (Diluted)	-0.57	-1.52	-3.99	-3.09	-4.63	Upgrade
Free Cash Flow	-96.57	-77.21	-71.52	-60.18	-48.23	Upgrade
Free Cash Flow Per Share	-0.54	-1.22	-2.78	-3.00	-4.18	Upgrade
Gross Margin	-	-	-	100.00%	-	Upgrade
Operating Margin	-	-	-	-1995.80%	-	Upgrade
Profit Margin	-	-	-	-2071.03%	-	Upgrade
Free Cash Flow Margin	-	-	-	-2006.00%	-	Upgrade
EBITDA	-93.32	-87.85	-83.15	-58.07	-49.99	Upgrade
EBITDA Margin	-	-	-	-1935.50%	-	Upgrade
Depreciation & Amortization	2	1.99	1.89	1.23	0.67	Upgrade
EBIT	-95.31	-89.85	-85.04	-59.3	-50.66	Upgrade
EBIT Margin	-	-	-	-1976.50%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).